Schlafen family is a prognostic biomarker and corresponds with immune infiltration in gastric cancer.

The Schlafen (SLFN) gene family plays an important role in immune cell differentiation and immune regulation. Previous studies have found that the increased SLFN5 expression in patients with intestinal metaplasia correlates with gastric cancer (GC) progression. However, no investigation has been conducted on the SLFN family in GC. Therefore, we systematically explore the expression and prognostic value of SLFN family members in patients with GC, elucidating their possible biological function and its correlation with tumor immune cells infiltration. TCGA database results indicated that the SLFN5, SLFN11, SLFN12, SLFN12L, and SLFN13 expression was significantly higher in GC. The UALCAN and KM plotter databases indicated that enhanced the SLFN family expression was associated with lymph node metastasis, tumor stage, and tumor grade and predicted an adverse prognosis. cBioportal database revealed that the SLFN family had a high frequency of genetic alterations in GC (about 12%), including mutations and amplification. The GeneMANIA and STRING databases identified 20 interacting genes and 16 interacting proteins that act as potential targets of the SLFN family. SLFN5, SLFN11, SLFN12, SLFN12L, and SLFN14 may be implicated in the immunological response, according to Gene Set Enrichment Analysis (GSEA) and Kyoto Encyclopedia of Genes and Genomes (KEGG). Additionally, Timer and TISIDB databases indicate that SLFN5, SLFN11, SLFN12, SLFN12L, and SLFN14 are involved in the immune response. Furthermore, Timer, TCGA, and TISIDB databases suggested that the SLFN5, SLFN11, SLFN12, SLFN12L, and SLFN14 expression in GC is highly linked with immune cell infiltration levels, immune checkpoint, and the many immune cell marker sets expression. We isolated three samples of peripheral blood mononuclear cell (PBMC) and activated T cells; the results showed the expression of SLFN family members decreased significantly when T cell active. In conclusion, the SLFN family of proteins may act as a prognostic indicator of GC and is associated with immune cell infiltration and immune checkpoint expression in GC. Additionally, it may be involved in tumor immune evasion by regulating T cell activation.

Xu J ，Chen S ，Liang J ，Hao T ，Wang H ，Liu G ，Jin X ，Li H ，Zhang J ，Zhang C ，He Y ... -  《Frontiers in Immunology》

Comprehensive analysis of bulk and single-cell RNA sequencing data reveals Schlafen-5 (SLFN5) as a novel prognosis and immunity.

Wu YJ ，Chiao CC ，Chuang PK ，Hsieh CB ，Ko CY ，Ko CC ，Chang CF ，Chen TY ，Nguyen NUN ，Hsu CC ，Chu TH ，Fang CC ，Tsai HY ，Tsai HC ，Anuraga G ，Ta HDK ，Xuan DTM ，Kumar S ，Dey S ，Wulandari FS ，Manalu RT ，Ly NP ，Wang CY ，Lee YK ... -  《International Journal of Medical Sciences》

Expression and regulation of Schlafen (SLFN) family members in primary human monocytes, monocyte-derived dendritic cells and T cells.

Puck A ，Aigner R ，Modak M ，Cejka P ，Blaas D ，Stöckl J ... -  《-》

Schlafen Family Intra-Regulation by IFN-α2 in Triple-Negative Breast Cancer.

Brown SR ，Vomhof-DeKrey EE ，Al-Marsoummi S ，Brown ND ，Hermanson K ，Basson MD ... -  《Cancers》

SCHLAFEN 5 expression correlates with intestinal metaplasia that progresses to gastric cancer.

Companioni Nápoles O ，Tsao AC ，Sanz-Anquela JM ，Sala N ，Bonet C ，Pardo ML ，Ding L ，Simo O ，Saqui-Salces M ，Blanco VP ，Gonzalez CA ，Merchant JL ... -  《-》